| ¿µ¹® | shock | ÇÑ±Û | ¼îÅ©, Ãæ°Ý |
|---|---|---|---|
| ¼³¸í | 1. Á¤½ÅÀû ÆòÇüÀÇ µ¹¿¬ÇÑ Àå¾Ö. 2. ¾î¶°ÇÑ ¿øÀÎÀ¸·Î ÁøÇ༺ÀÎ ¸»ÃʼøÈ¯ºÎÁ·ÀÇ °á°ú·Î Á¶Á÷ÀÇ »ê¼ÒºÎÁ·ÁõÀ» ÀÏÀ¸ÄÑ Åº»ê°¡½º³ª À¯»êµîÀÇ ´ë»ç»ê¹°ÀÇ ÃàÀûÀ» ÀÏÀ¸Å² »óŸ¦ ¸»ÇÑ´Ù. ¼îÅ©ÀÇ ÀÓ»óÁõ»óÀº ¨ç ÇǺÎÀÇ Ã¢¹é, ¨è ¼Õ¹ßÅé¸ð¼¼Ç÷°üÀÇ ÀçÃæ¸¸ Áö¿¬, ¨é ÀǽÄÀå¾Ö, ¨ê Ç÷¾ÐÇϰ, ¸Æ¹Ú±äÀåÀúÇÏ, ¨ë ¿ä·®°¨¼Ò µîÀÌ´Ù. ¼îÅ©ÀÇ ºÐ·ù¿¡´Â 1Â÷¼º¼îÅ©, 2Â÷¼º¼îÅ©°¡ ÀÖÀ¸¸ç ¼øÈ¯µ¿Å¿¡ ÀÇÇÑ ºÐ·ù·Î¼ ÀúÇ÷·ù·®¼º¼îÅ©, ¸»ÃÊÇ÷°üÈ®À强¼îÅ©, ½ÉÀ强¼îÅ©°¡ ÀÖ´Ù. º´ÀÎÀûÀÎ ºÐ·ù·Î¼ ½Å°æÅ¿¼îÅ©, ¾Æ³ªÇǶô½Ã½º¼îÅ©, ±¹¼Ò¸¶Ãë¾à Áßµ¶ÀÇ °á°ú·Î ÀϾ´Â ¼îÅ© µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | osmotic pressure | ÇÑ±Û | »ïÅõ¾Ð |
|---|---|---|---|
| ¼³¸í | »ïÅõ¶ó´Â Çö»óÀº ÀÏÁ¤ Å©±â ÀÌÇÏÀÇ ¹°ÁúÀº Åë°ú½ÃŰ°í ±× ÀÌ»óÀÇ Å©±â¸¦ °¡Áø ¹°ÁúÀº Åë°ú ½ÃŰÁö ¸øÇÏ°Ô ÇÏ´Â ¸·(¹ÝÅõ¸·)À» »çÀÌ¿¡ µÎ°í ¾çÂÊ¿¡ ±× ¸·À» Åõ°úÇÏÁö ¸øÇÏ´Â ¹°ÁúÀÇ ³óµµ°¡ Â÷À̰¡ ³¯ ¶§ ¹ß»ýÇÏ´Â °ÍÀ¸·Î ¸·À» Åë°úÇÒ ¼ö ÀÖ´Â ¹°ÁúÀÌ ¸· ¾çÂÊÀÇ Åë°ú ÇÒ ¼ö ¾ø´Â ¹°ÁúÀÇ ³óµµ¸¦ °°°Ô ÇÏ´Â ¹æÇâÀ¸·Î ¿òÁ÷ÀÌ´Â °ÍÀ» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | osmotic fragility | ÇÑ±Û | »ïÅõ¾ÐÃë¾à¼º |
|---|---|---|---|
| ¼³¸í | ÀûÇ÷±¸¼¼Æ÷ÀÇ »ïÅõ¾Ð Ư¼º º¯È¿¡ ´ëÇÑ ¹Î°¨¼º. ÀûÇ÷±¸°¡ Àú³óµµÀÇ ³ªÆ®·ý ¿ë¾×¿¡ ³ëÃâÇÏ¸é ¼¼Æ÷¸·ÀÇ ´É·ÂÀ» ÃʰúÇÒ ¶§±îÁö ´Ù·®ÀÇ ¹°À» Èí¼öÇÏ¿© ºÎÇ®¾î¿Ã¶ó ÆÄ¿ÇÏ°í °í³óµµÀÇ ³ªÆ®·ý ¿ë¾×¿¡ ³ëÃâÇϸé ÀûÇ÷±¸ÀÇ ¼¼Æ÷³»¾×ÀÌ ºüÁ®³ª°¡ Å©±â°¡ ÁÙ¾îµé¸ç ÆÄ±«µÈ´Ù. ¿¹¿ÜÀû Ãë¾à¼ºÀ̳ª ÀúÇ×¼ºÀº ƯÁ¤ º´ÀÇ Áø´ÜÀû ±âÁØÀÌ µÉ¼ö ÀÖ´Ù. Á¤»ó¼¼Æ÷´Â 0.39~0.45% ¼Ò±Ý¹° ¿ë¾×¿¡¼ ¿ëÇ÷ÀÌ ½ÃÀ۵Ǹç, 37¡É(98.6¢µ)¿¡¼ 0.30~0.33% ¼Ò±Ý ¿ë¾×¿¡ ÀûÇ÷±¸¸¦ ³ëÃâ½ÃŰ¸é ¿ëÇ÷Àº 24½Ã°£ À̳»¿¡ ¿Ï·áµÈ´Ù. |
||
| COP | capillary osmotic pressure; change of plaster; coefficient of performance; colloid oncotic pressure;... |
|---|---|
| HOST | hypo-osmotic shock treatment |
| COP | i colloid osmotic pressure in interstitial fluid |
| COPp | colloid osmotic pressure in plasma |
| ODS | organized delivery system; osmotic demyelination syndrome |
| COP | Colloid osmotic pressure |
|---|---|
| HOST | Hypo-osmotic swelling test |
| HOS | hypo-osmotic swelling test |
| HSP | 2)/heat shock protein |
| ESWL | 2--extracorporeal shock-wave lithotripsy |
| osmotic shock | Passage of solvent into a membrane bound structure due to osmosis, causing rupture of the membrane. A method of lysing cells or organelles. (18 Nov 1997) |
|---|
| diuretics, osmotic | Diuretics that are filtered at the glomerulus and reabsorbed in the renal tubule only to a limited extent. They thus increase the amount of osmotically active solute in the urine and a corresponding increase in urine volume. These compounds also increase the osmolality of plasma, thereby increasing the diffusion of water from the intraocular and cerebrospinal fluids; they can be used for reducing the pressure and volume of these fluids. (12 Dec 1998) |
|---|---|
| iso-osmotic | <physiology> Having the same total osmotic pressure or osmolality as another fluid (ordinarily intracellular fluid); such a fluid is not isosmotic if it includes solutes that freely permeate cell membranes. Synonym: iso-osmotic. (05 Mar 2000) |
| osmotic | <chemistry> Pertaining to or of the nature of osmosis (= the passage of pure solvent from a solution of lesser to one of greater solute concentration when the two solutions are separated by a membrane which selectively prevents the passage of solute molecules, but is permeable to the solvent). (18 Nov 1997) |
| osmotic diuresis | Diuresis due to a high concentration of osmotically active substances in the renal tubules (e.g., urea, sodium sulfate), which limit the reabsorption of water. (05 Mar 2000) |
| osmotic diuretics | Drugs, such as mannitol, which by their osmotic effects retain water during urine formation and thus dilute electrolytes in the urine, making resorption less efficient; they promote the elimination of water and electrolytes in the urine. (05 Mar 2000) |
| osmotic fragility | The susceptibility, or lack of resistance, of erythrocytes to haemolysis when exposed to increasingly hypotonic saline solutions. (12 Dec 1998) |
| osmotic nephrosis | Swelling of renal tubular epithelium associated with glomerular filtration of sugars and dextrose; the swelling is due to formation of cytoplasmic vesicles by pinocytosis, and is reversible, probably with no dysfunction, when produced by glucose or mannitol. (05 Mar 2000) |
| osmotic pressure | See: osmosis. The pressure required to prevent osmotic flow across a semi permeable membrane separating two solutions of different solute concentration. Equal to the pressure that can be set up by osmotic flow in this system. (18 Nov 1997) |
| effective osmotic pressure | That part of the total osmotic pressure of a solution that governs the tendency of its solvent to pass across a boundary, usually a semipermeable membrane; it is commonly represented by the product of the total osmotic pressure of the solution and the ratio (corrected for activities) of the number of dissolved particles that do not permeate the bounding membrane to the total number of particles in the solution; equivalent in meaning to tonicity; commonly expressed in equivalent units of osmolality rather than pressure per se. (05 Mar 2000) |
| anaesthetic shock | Shock produced by the administration of anaesthetic drug(s), usually in relative overdosage. (05 Mar 2000) |
| anaphylactic shock | <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing. (27 Sep 1997) |
| anaphylactoid shock | A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions. Synonym: anaphylactoid crisis, pseudoanaphylactic shock. (05 Mar 2000) |
| break shock | The shock produced by breaking a constant current passing through the body. (05 Mar 2000) |
| cardiac shock | A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy. Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully. (27 Sep 1997) |
| cardiogenic shock | A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy. Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully. (27 Sep 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|